Head of Corporate Development and Business Development

ALLInBio, Inc.; Palo Alto (CA); Ibrido; USD 250.000 - 450.000; Tempo pieno

Descrizione del lavoro

ALLInBio, Inc. in Palo Alto seeks a Head of Corporate Development & Business Development to drive growth through strategic partnerships, licensing, and asset acquisitions. The role reports to the CEO and collaborates with scientific leadership, the Board, and investors.

The ideal candidate has a proven BD track record in pharma/biotech, deep drug-discovery insight, and leads due diligence, deal structuring, and end-to-end negotiations. In-person collaboration with the executive team is expected.

Competenze

• Proven corporate and business development experience in pharma/biotech.
• Ability to evaluate scientific/clinical data and novel mechanisms.
• Experience leading complex negotiations and due diligence.
• Strong financial and commercial judgment for asset valuation.
• Excellent communication, presentation, and negotiation skills.
• Advanced degree preferred (PhD/MD or equivalent).

Mansioni

• Oversee corporate governance, records, and external advisors.
• Collaborate with CEO on budgeting and deal-related spend.
• Develop and execute BD strategy aligned with growth goals.
• Build relationships with pharma/biotech firms, academia, and researchers.
• Lead due diligence and present business cases to Board and exec team.
• Negotiate licensing, asset acquisitions, and collaborations.
• Own end-to-end deal execution from term sheet to alliance management.

Conoscenze

Negotiation skills

Communication skills

Industry network

Strategic thinking

Formazione

Advanced scientific or medical degree (PhD, MD, or equivalent) preferred

Strumenti

AI tools

Descrizione del lavoro

HEAD OF CORPORATE DEVELOPMENT & BUSINESS DEVELOPMENT

Senior executive role; title commensurate with the selected candidate's experience

Location

Reporting to

Chief Executive Officer

Position Overview

We are seeking an entrepreneurial corporate and business development executive to help shape the company's growth strategy through strategic partnerships, licensing, and the acquisition of innovative therapeutic assets.

The ideal candidate combines a proven deal track recordwith a deep scientific understanding of drug discovery, and clinical development. The role works closely with the CEO, scientific leadership, the Board and investors.

The company operates virtually from its offices in Palo Alto and values frequent in-person interaction and scientific discussion. Candidates should be available to meet regularly in person with the executive team.

Key Responsibilities

Corporate G&A Oversight

• Oversee day-to-day corporate general and administrative matters, including contract administration, legal and IP coordination, and management of outside advisors and service providers.
• Work with finance and the CEO on budgeting, transaction-related expenses, and the corporate records and governance documentation that support financing efforts, deals and Board activities.
• Develop and execute the corporate and business development strategy in line with corporate goals regarding pipeline development and short to mid-term value creation.
• Build and maintain relationships with pharmaceutical and biotechnology companies, academic institutions, and research organizations to access innovative assets, technologies, and collaborations.
• Work with the CEO and leadership team on corporate planning, prioritization, and Board-level initiatives.
• Support financing activities and investor discussions as needed.
• Strengthen the company's external profile and reputation across the industry.

Asset Sourcing & Evaluation

• Proactively source therapeutic assets and technologies that complement the company's scientific capabilities and strategic priorities.
• Partner with scientific leadership to assess biological rationale, mechanism of action, preclinical and clinical data, biomarker strategy, and competitive landscape.
• Evaluate commercial opportunities, clinical differentiation, development risk, and return on investment, and identify where the company's expertise can create differentiated value.
• Lead multidisciplinary due diligence (scientific, clinical, regulatory, IP, commercial, and financial) and present business cases to executive management and the Board.

Deal Structuring & Execution

• Lead negotiation and execution of licensing agreements, asset acquisitions, research collaborations, and co-development partnerships.
• Design deal economics, including upfront payments, milestones, royalties, and equity components, working with legal and financial advisors on definitive agreements.
• Own transactions end to end, from term sheet through contract execution and alliance management.

Qualifications & Experience Required

• Significant corporate and business development experience in the pharmaceutical or biotechnology industry, with a track record of completed transactions, preferably in-licensing of therapeutic assets.
• Ability to independently evaluate differentiating scientific and clinical data and novel mechanisms.
• Experience leading complex negotiations and multidisciplinary due diligence.
• Sound financial and commercial judgment in asset valuation, deal economics, and development risk.
• An established industry network and excellent communication, presentation, and negotiation skills.
• Advanced scientific or medical degree (PhD, MD, or equivalent) preferred.
• Strong command of the use of AI tools.

Preferred

• Experience in large pharmaceutical or smaller, entrepreneurial biotech settings.
• Experience with early-stage (preclinical and clinical) programs and regulatory development.
• Direct experience working with CEOs, investors, and Boards of Directors.
• Broad background, preferably in autoimmune, inflammatory, or immunology and fibrotic therapeutic areas.

Personal Attributes

• Entrepreneurial, intellectually curious, and highly motivated with exemplary work ethic.
• Positive thinker and pragmatic problem solver.
• Strategic yet very comfortable with hands-on execution.
• Scientifically rigorous, able to separate compelling biology from insufficiently validated opportunities.
• A credible relationship builder with senior pharma executives, scientists, investors, and partners.
• Collaborative and adaptable in a small, dynamic organization, and willing to engage frequently in person.
• Excellent written and verbal presentation skills